NL
NL · NL · NL-f16b1a8e5bfa
Seffalair Spiromax 14/232 µg, inhalatiepoeder
ATC R03AK06
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerTeva B.V.
CountryNL (NL)
ATC codeR03AK06
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/21/1533
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Inhalatiepoeder",
"route": "Inhalatie",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/seffalair-spiromax-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Salmeterol and fluticasone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp125772",
"excipients": [
"LACTOSE 1-WATER"
],
"substances": [
"FLUTICASONPROPIONAAT",
"SALMETEROLXINAFOAAT"
],
"leaflet_url": null,
"authorised_at": "2021/03/26",
"procedure_number": "EMEA/H/C/004881",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1533",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code R03AK06.
Access this data programmatically
Query Seffalair Spiromax 14/232 µg, inhalatiepoeder and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.